Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 12-24

  Pilcher, Brian K ^a,b   Wang, Min ^a   Qin, Xue Jin ^a   Parks, William C ^a   Senior, Robert M ^a   Welgus, Howard G ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; COLLAGEN TYPE 1; COLLAGENASE; GELATINASE B; INTEGRIN; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; STROMELYSIN 2;

BASEMENT MEMBRANE; CELL CONTACT; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTACT DERMATITIS; EPIDERMIS; FIBROBLAST; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; NONHUMAN; SKIN ALLERGY; SKIN INJURY; SKIN ULCER; SURGICAL WOUND; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

EID: 0032815514     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07671.x     Document Type: Conference Paper

References (34)

1. 1. Chandler, S., R. Coates, A. Gearing, J. Lury, G. Wells & E. Bone. 1995. Matrix metalloproteinases degrade myelin basic protein. Neuroscience Lett. 201: 223-226.
2. 2. Sires, U.I., G. Murphy, H.G. Welgus & R.M. Senior. 1994. Matrilysin is much more efficient than other metalloproteinases in the proteolytic inactivation of a1-antitrypsin. Biochem. Biophys. Res. Commun. 204: 613-620.
3. 3. Agren, M., C. Taplin, J. Woessner, W. Eaglestein & P. Mertz. 1992. Collagenase in wound healing: effect of wound age and type. J. Invest. Dermatol. 99: 709-714.
4. 4. Buckley-Sturrock, A., S.C. Woodward, R.M. Senior, G.L. Griffin, M. Klagsbrun & J.M. Davidson. 1989. Differential stimulation of collagenase and chemotatic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J. Cell. Physiol. 138: 70-78.
5. 5. Wysocki, A.B., L. Staiano-Coico & F. Grinnell. 1993. Wound fluid from chronic leg ulcers contains elevated levels of metalloprotetnases MMP-2 and MMP-9. J. Invest. Dermatol. 101: 64-68.
6. 6. Saarialho-Kere, U.K., S.O. Kovacs, A.P. Pentland, J. Olerud, H.G. Welgus & W.C. Parks. 1993. Cell-matrix interactions influence interstitial collagenase expression by human keratinocytes actively involved in wound healing. J. Clin. Invest. 92: 2858-2866.
7. 7. Saarialho-Kere, U.K., S.O. Kovacs, A.P. Pentland, W.C. Parks & H.G. Welgus. 1994. Distinct populations of keratinocytes express stromelysin-1 and -2 in chronic wounds. J. Clin. Invest. 94: 79-88.
8. 8. Saarialho-Kere, U.K., E.S. Chang, H.G. Welgus & W.C. Parks. 1992. Distinct localization of collagenase and TIMP expression in wound healing associated with ulcerative pyogenic granuloma. J. Clin. Invest. 90: 1952-1957.
9. 9. Saarialho-Kere, U., M. Vaalamo, K. Airola, K.-M. Niemi, A.I. Oikarinen & W.C. Parks. 1995. Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin diseases. J. Invest. Dermatol. 104: 982-988.
10. 10. Stricklin, G.P., L. Li & L.B. Nanney. 1994. Localization of mRNAs representing interstitial collagenase, 72 kDa gelatinase, and TIMP in healing porcine burn wounds. J. Invest. Dermatol. 103: 352-358.
11. 11. Stricklin, G.P. and L.B. Nanney. 1994. Immunolocalization of collagenase and TIMP in healing human burn wounds. J. Invest. Dermatol. 103: 488-492.
12. 12. Stricklin, G.P., L. Li, V. Jancic, B.A. Wenczak & L.B. Nanney. 1993. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am. J. Path. 143: 1657-1666.
13. 13. Birkedal-Hansen, H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735.
14. 14. Vaalamo, M., M. Weckroth, P. Puolakkainen, J. Kere, P. Saarinen, J. Lauharanta & V. Saarialho-Kere. 1996. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br. J. Dermatol. 135: 52-59.
15. 15. Okada, A., C. Tomasetto, Y. Lutz, J.-P. Bellocq, M.-C. Rio & P. Basset. 1997. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of progelatinase A. J. Cell Biol. 137: 67-77.
16. 16. Librach, C.L., Z. Werb, M.L. Fiztgerald, K. Chiu, N.M. Corwin, R.A. Esteves, D. Grobelny, R. Galardy, C.H. Damsky & S.J. Fisher. 1991. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113: 437-449.
17. 17. Wilcox, B.D., J.A. Dumin & J.J. Jeffrey. 1994. Serotonin regulation of IL-1 mRNA in rat uterine smooth muscle cells. J. Biol. Chem. 269: 29658-29664.
18. 18. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, M.J. Bissell & Z. Werb. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693.
19. 19. DeSouza, S., J. Lochner, C.M. Machida, L.M. Matrisian & G. Ciment. 1995. A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells. J. Biol. Chem. 270: 9106-9114.
20. 20. Sudbeck, B.D., B.K. Pilcher, H.G. Welgus & W.C. Parks. 1997. Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J. Biol. Chem. 272: 22103-22110.
21. 21. Reboul, P., J.-P. Pelletier, G. Tardif, J.-M. Cloutier & J. Martel-Pelletier. 1996. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J. Clin. Invest. 97: 2011-2019.
22. 22. Yamamoto, M., S. Mohanam, R. Sawaya, G.N. Fuller, M. Seiki, H. Sato, Z.L. Gokaslan, L.A. Liotta, G.L. Nicolson & J.S. Rao. 1996. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56: 384-392.
23. 23. Neumunaitis, J., C. Poole, J. Primrose, A. Rosemurgy, J. Malfetano, P. Brown, A. Berrington, A. Cornish, K. Lynch, H. Rasmussen, D. Kerr, D. Cox & A. Millar. 1998. Combined analysis of studies of the effect of the MMP inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin. Cancer Res. 4: 1101-1109.
24. 24. Thompson, R.W., D.R. Holmes, R.A. Mertens, S. Liao, M.D. Botney, R.P. Mecham, H.G. Welgus & W.C. Parks. 1995. Production and localization of 92 kD gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318-326.
25. 25. Galis, Z.S., G.K. Sukhova, R. Kranzhofer, S. Clark & P. Libby. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA. 92: 402-406.
26. 26. Vaalamo, M., M. Weckroth, P. Puolakkainen, J. Kere, P. Saarinen, J. Lauharanta & U. Saarialho-Kere. 1996. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Brit. J. Dermatol. 135: 52-59.
27. 27. Pilcher, B.K., J. Dumin, M.J. Schwartz, B.A. Mast, G.S. Schultz, W.C. Perks & H.G. Welgus. 1999. Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J. Biol. Chem. 274: 10372-10381.
28. 28. Pilcher, B.K., B.D. Sudbeck, J. Dumin, S.M. Krane, H.G. Welgus & W.C. Parks. 1997. The activity of collagenase-1 is required for keratinocyte migration on type I collagen. J. Cell Biol. 137: 1445-1457.
29. 29. Liu, X., H. Wu, M. Byrne, J. Jeffrey, S. Krane & R. Jaenisch. 1995. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130: 227-237.
30. 30. Krane, S.M., M.H. Byrne, V. Lemaitre, P. Henriet, J.J. Jeffrey, J.P. Witter, X. Liu, H. Wu, R. Jaenisch & Y. Eeckhout. 1996. Different collagenase gene products have different roles in degradation of type I collagen. J. Biol. Chem. 271: 28509-28515.
31. 31. Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb & M.J. Bissell. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139: 1861-1872.
32. 32. Ferguson, T.A., P. Dube & T.S. Griffith. 1994. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179: 1597-1604.
33. 33. Mosmann, T.R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56: 1-26.
34. 34. Wang, M., X. Qin, J.S. Mudgett, T.A. Ferguson, R.M. Senior, and H.G. Welgus. 1999. Metalloproteinase deficiencies alter contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. (USA). In press.